Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

share repurchase

31 posts
NNovo Nordisk
Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-05-13
Novo Nordisk A/S Bagsværd, Denmark, 20 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase…
NNovo Nordisk
Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing
Read More

Novo Nordisk completes DKK 3.8B share buyback | NVO SEC Filing

  • 2026-05-05
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   ________________   FORM 6-K ________________   REPORT…
NNovo Nordisk
Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-05-05
Novo Nordisk A/S Bagsværd, Denmark, 5 May 2026 – On 4 February 2026, Novo Nordisk initiated a share…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-05-05
Novo Nordisk A/S Bagsværd, Denmark, 5 May 2026 – On 4 February 2026, Novo Nordisk initiated a share…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-05-04
Novo Nordisk A/S Bagsværd, Denmark, 20 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-04-27
Novo Nordisk A/S Bagsværd, Denmark, 27 April 2026 – On 4 February 2026, Novo Nordisk initiated a share…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-04-20
Novo Nordisk A/S Bagsværd, Denmark, 20 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase…
NNovo Nordisk
Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-04-17
Novo Nordisk A/S Bagsværd, Denmark, 13 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-04-14
Novo Nordisk A/S Bagsværd, Denmark, 13 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase…
NNovo Nordisk
Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing
Read More

Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing

  • 2026-04-07
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   ________________   FORM 6-K ________________   REPORT…
NNovo Nordisk
Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
Read More

Novo Nordisk A/S – Share repurchase programme

  • 2026-04-07
Novo Nordisk A/S Bagsværd, Denmark, 7 April 2026 – On 4 February 2026, Novo Nordisk initiated a share…
NNovo Nordisk
Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-04-02
Novo Nordisk A/S Bagsværd, Denmark, 30 March 2026 – On 4 February 2026, Novo Nordisk initiated a share…
Denmark
www.europesays.com